Michaela J. Feodoroff

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Precision tumor-on-chip for personalized assessment of drug efficacy and immune cell delivery.

Precision tumor-on-chip for personalized assessment of drug efficacy and immune cell delivery.

Journal: Cell reports methods

Published: December 19, 2025

Novel therapeutic strategies for ccRCC through integration of systemic drug combinations and oncolytic adenovirus immunotherapy.

Novel therapeutic strategies for ccRCC through integration of systemic drug combinations and oncolytic adenovirus immunotherapy.

Journal: Frontiers in immunology

Published: December 04, 2025

Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC.

Patient-derived tumor organoids for personalized cancer immunotherapy: An immunopeptidome-to-validation approach in RCC and BC.

Journal: Molecular therapy. Oncology

Published: October 29, 2025

Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy.

Effect of extracellular vesicles in remodeling the tumor microenvironment by DNMT1 downregulation for enhanced cancer immunotherapy.

Journal: Journal for immunotherapy of cancer

Published: October 10, 2025

Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response.

Leveraging glucan-induced trained immunity for the epigenetic and metabolic rewiring of macrophages to enhance colorectal cancer vaccine response.

Journal: Nature communications

Published: April 16, 2025

Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses.

Enhancing T-cell recruitment in renal cell carcinoma with cytokine-armed adenoviruses.

Journal: Oncoimmunology

Published: October 01, 2024

Functional screening identifies kinesin spindle protein inhibitor filanesib as a potential treatment option for hepatoblastoma.

Functional screening identifies kinesin spindle protein inhibitor filanesib as a potential treatment option for hepatoblastoma.

Journal: NPJ precision oncology

Published: August 06, 2024

Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.

Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors.

Journal: Journal for immunotherapy of cancer

Published: February 18, 2024

Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.

Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.

Journal: Antiviral research

Published: November 15, 2023

Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy.

Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy.

Journal: Molecular therapy. Oncology

Published: July 18, 2023

Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets.

Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets.

Journal: European urology focus

Published: December 09, 2022

Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors.

Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors.

Journal: Nature communications

Published: November 04, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026